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5 deaminase (yCD) (Korkegian et al., 2005) . The 153 amino acid protein displays irreversible unfolding behavior at high temperature. RosettaDesign (Kuhlman et al., 2000) was used to evaluate the fitness of a particular sequence for a given fold, and a Monte Carlo search algorithm was used for sampling sequence space. The program requires a backbone structure as input, uses an empirical energy function, and generates sequences predicted to have the lowest energy for that fold. Excluding the residues located within 4 Å of the active site or involved in the dimer interface, or examined in other published studies, their computational design of the yCD mutants only needed to consider possible mutations on 33 amino acid residues.
CocE represents a considerably more challenging enzyme to computationally derive a thermostable enzyme due to its relatively large size (574 amino acids). Firstly, the computational design and subsequent experimental tests need to take into account many more amino acid residues in order to identify the best possible thermostable mutations. In addition, it is unnecessary for the enzyme to unfold before it becomes inactive. Enzyme inactivation could be merely associated with minor structural changes on the least-stable region of the protein, without completely unfolding the enzyme. In this case, a mutation lowering the total folding energy of an enzyme does not necessarily lead to a longer half-life of the active enzyme structure. Hence, it is crucial to uncover the inactivation mechanism while modeling thermostabilization of an enzyme.
like CocE can be performed for as long as nanoseconds using currently available supercomputers. Instead, we based our computational design strategy on an analysis of the kinetic relationship between the inactivation rate constant (k ina ) and the temperature (T) for a given inactivation free energy barrier (ΔG ina ) of the inactivation process, i.e. k ina = (k B T/h)exp(-ΔG ina /RT),
which is analogous to the rate constant equation used in the well-known variational transition state theory (Corchado et al., 1998) . In Eq.
(1), k B is Boltzmann's constant and h is Planck's constant. According to Eq.(1), the rate constant k ina of the enzyme inactivation is dependent on the temperature for a given inactivation free energy barrier. The higher the temperature, the larger the rate constant and, therefore, the half-life of the active enzyme is shorter. This kinetic understanding enables us to reveal the inactivation pathway of CocE through performing MD simulation at an appropriately high temperature. The high temperature used in the MD simulations is physiologically irrelevant, but can considerably shorten the time of the protein inactivation process and, thus, allows us to observe the protein inactivation process within nanoseconds.
The initial structures constructed from the X-ray crystal structure (Larsen et al., 2002) were neutralized by adding sodium counterions and were solvated in a rectangular box of TIP3P
water molecules with a minimum solute-wall distance of 10 Å. All of the MD simulations were performed by using the Sander module of Amber 8 package (Case et al., 2004) . The solvated systems were carefully equilibrated and fully energy-minimized. These systems were gradually heated from T = 10 K to T = 298 K in 30 ps before production MD simulations at 298 K (in the NPT ensemble with P = 1 atm) and then at 575 K (in the NVT ensemble). The time step used for the MD simulations was 2 fs. Periodic boundary conditions with Berendsen temperature coupling (Berendsen et al., 1984) with isotropic molecule-based scaling (Berendsen et al., 1984) were applied. The SHAKE algorithm (Ryckaert et al., 1977) was used to fix all covalent bonds containing hydrogen atoms. The non-bonded pair list was updated every 10 steps. The particle mesh Ewald (PME) method (Darden et al., 1993) was used to treat long-range electrostatic interactions. A residue-based cutoff of 10 Å was utilized to the non-covalent interactions.
Further, the protein structures simulated at 298 K were subjected to the energy minimization prior to the interaction energy calculations in the gas phase. The solvent shifts of the interaction energies were calculated by using the Delphi program (Gilson et al., 1988) . In addition, the This article has not been copyedited and formatted. The final version may differ from this version. Purification of cocaine esterase and mutants. Cells were pelleted, resuspended in 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM dithiothreitol (DTT), and a protease inhibitor coctail (34 μg/ml each of L-tosylamido-2-phenylethyl chloromethyl ketone, 1-chloro-3-tosylamido-7-amino-2-heptanone and phenylmethylsulfonyl fluoride, and 3 μg/ml each of leupeptin and lima bean trypsin inhibitor) and lysed using a French press (Thermo Fisher Scientific Corp, USA). 6xHis-tagged enzymes were enriched using Talon metal affinity chromatography (Clontech Laboratories, Inc, Mountain View CA) and purified using anion- Michaelis-Menten kinetics of cocaine hydrolysis. Cocaine hydrolysis was monitored as previously described (Turner et al., 2002) . The initial rates of decay were estimated by following the change in the intrinsic absorbance of cocaine at 240 nm with time using a SpectraMax Plus 384 UV plate reader (Molecular Devices, Sunnyvale, CA) and SOFTmax Pro software (Version 3.1.2). The initial rates were estimated from the linear portion of the progress curves and spanned no longer than 5 minutes. The reaction was initiated by adding 100 μL of a 2X enzyme solution (100 mM Phosphate Buffer, pH 7.4 and 300 mM NaCl) to 100 μL of a 2X cocaine solution (50 ng/mL enzyme, 100 mM Phosphate Buffer, pH 7.4 and 300 mM NaCl). Final cocaine concentrations were as follows: 125, 62.5, 31.25, 15.63, 7.81, 3.91, 1.95, and 0.977 μM. V max and K M values were calculated using Prism (GraphPad Software, San Diego). Stability measurements were performed using the native and mutant enzymes diluted to 2X concentration This article has not been copyedited and formatted. The final version may differ from this version.
and incubated at 37 o C for various times. At the end of each time point, an aliquot was removed and kinetic behavior was observed as mentioned above. Percent remaining activity was plotted against time to assess the half-life (τ 1/2 ) of each enzyme.
Circular dichroism measurement and thermal denaturation experiments. CD data
were collected on a J-810 spectropolarimeter (JASCO, Easton, MD). Near-UV wavelength scans were run from 250 -320 nm with a 0.2 nm pitch, varying protein concentrations (5 -30 µM), temperatures increasing from 5 -70°C in 2.5°C increments, and a 1 cm pathlength waterjacketed cylindrical quartz cell. Four elliptical curves were generated per temperature measurement, and denaturation was recorded as a change in average elipticity over temperature.
Apparent Tm's were determined by deconvolution to component spectra using the convex constraint algorithm (Perczel et al., 1992) into 2 curves using 30 iterations, and subsequent nonlinear regression curve-fitting using Prism 5 (GraphPad Sofware, San Diego, CA). ice. Samples were spun at 4000 rpm for 5 minutes to separate the plasma. 10 μg of plasma proteins were loaded onto a 10% SDS-PAGE gel and transferred onto a nitrocellulose membrane. Membranes were then probed with anti-CocE rabbit antibody followed by HRPlinked anti-rabbit secondary antibody. As a loading control, blots were stripped and then reprobed with mouse anti-apolipoprotein-A1 antibody.
In vivo

Results
We used Amber (Case et al., 2004) to carry out MD simulations on native CocE in water.
The simulations, starting from the X-ray crystal structure (Larsen et al., 2002) of CocE, were performed first at room temperature (298 K) for 250 ps followed by an increase in temperature to 575 K for 1050 ps (i.e. 250 ps to 1300 ps in Figure 1 (A)). Depicted in Figure 1 (A) is the timedependence of the root-mean-square-deviation (RMSD) of the atomic positions in the simulated CocE structure from the corresponding positions in the X-ray crystal structure. The RMSD value reflects the magnitude of the overall change of the protein structure during the MD simulation. A stable protein structure is usually expected to have a reasonable RMSD value of ~2 Å for the overall protein structure due to dynamics of protein in water. A significantly larger RMSD value may be associated with some major structural change that could cause the protein to lose its normal function. Figure 1 (A) shows that the CocE structure was quickly stabilized during the MD simulation at 298 K. The RMSD value became increasingly larger during the further MD simulation at 575 K and reached a value for the overall protein structure of 4 Å at ~1000 ps. In order to identify the pathway for the major structural change of CocE during the MD simulation at 575 K, we further visualized the detailed structural changes during the MD simulation and found that amino acid residues G165 to I195 in domain II (consisting of amino acid residues D145 to L240) of CocE first started to have the major structural changes. Figure 1 (B) depicts the three domains (I to III) of CocE. As seen in Figure 1(B) , part of the substrate-binding pocket belongs to domain II. Based on the MD simulation, the region from residues G165 to I195 in domain II is the least stable region of the CocE structure. As seen in Figure 1( to I195 in domain II, decreasing the total folding energy by stabilizing domain I or III should not increase the half-life of the active enzyme structure.
The above mechanistic insights obtained from the MD simulations suggest that rational design of possible thermostable mutants of CocE should therefore focus on domain II, particularly residues G165 to I195. This may be accomplished by increasing either hydrogen bonding between domains I and II or by increasing some favorable interactions between amino acid residues within domain II. Hence, our current computational design only targets residues of domain II that are at least 5 Å away from (-)-cocaine atoms according to our modeled CocE-(-)-cocaine complex structure. The energetics of possible mutations on these amino acid residues were estimated by using two different approaches. The first approach calculates the shift in the interaction energy between the mutated residue and the remaining part of the enzyme, through a combined application of Amber and Delphi (Gilson et al., 1988) programs. The structures of both native CocE and mutants were optimized (through energy minimization) prior to the interaction energy calculations.
The other approach estimates the change in folding energy of the mutant by using the RosettaDesign program for folding energy calculations on the optimized structures of native CocE and its mutants. These two computational approaches can complement each other.
Whereas the former uses a more sophisticated theoretical energetic approach, the later uses the empirical scoring function developed specifically for folding energy calculations. We can reasonably expect that when both approaches consistently predict that a mutation on a residue in domain II can stabilize domain II, the prediction should be more reliable. Indeed, both computational approaches consistently predicted that several mutations, including T172R and G173Q, should stabilize domain II. Mutation G173Q was predicted to build a bridge between domains I and II through a hydrogen bond between residues P43 of domain I and Q173 of domain II (see Figure 1 (C)), whereas mutation T172R was predicted to have an improved interaction between residue #172 and the other residues in domain II (with a lower interaction/folding energy). The CocE-wt crystal structure (Larsen et al., 2002) reveals that the alkyl chain of Thr172 on helix 5 points toward helix 6 within domain II but away from domain I.
Substitution of arginine at this location introduces a longer alkyl moiety and a charge that we
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Mutant enzymes were generated by site-directed mutagenesis and expressed and purified as described previously (Cooper et al., 2006) . The in vitro enzyme activity depicted in Figure 2 (B) reveal that preincubation of native CocE at 37°C decreased the enzymatic activity exponentially with time (τ 1/2 = ~11 ± 0.9 min). In contrast, the CocE mutants T172R, G173Q, and T172R/G173Q displayed significantly longer half-lives without changing the enzymatic activity prior to preincubation at 37°C: τ 1/2 (T172R) = ~78 ± 6.5 min (~7-fold increase), τ 1/2 (G173Q) = ~75 ± 9.9 min (~7-fold increase), and τ 1/2 (T172R/G173Q) = ~305 ± 38 min (~30-fold increase). Careful analysis of the activity of T172R/G173Q following incubation at 37°C
suggests a more complicated mechanism of inactivation at 37°C compared to CocE-wt or the single mutants. While CocE-wt, T172R and G173Q fit very well to a single-phase exponential decay, T172R/G173Q displays multi-phase inactivation kinetics with τ 1/2short~1 80 min and τ 1/2long~4 900 min. Although we have little data to pinpoint a precise mechanism for the biphasic appearance the data do reflect the cooperative, rather than additive, effects of combining T172R
and G173Q mutations. These data correlated well with subsequent circular dichroism measurements (Figure 3 ) of thermal denaturation, revealing a 3.1 -3.5°C increase in apparent denaturation temperature (T m ) for single mutants and a 7.1°C increase for the double mutant Assessment of the thermostability using in vivo models based on protection of native CocE (CocE-wt) and its T172R and T172R/G173Q mutants against cocaine-induced lethality correlated well with the in vitro data. Depicted in Figure 4 (A) are the determined in vivo halflives of the enzymes in comparison with the corresponding in vitro half-lives at 37°C. As seen in Figure 4 (A), the in vivo half-life of CocE-wt is ~11 ± 1.4 min, whereas both the T172R and T172R/G173Q mutants have significantly longer half-lives, i.e. ~95 ± 13 min (~9-fold increase) and ~262 ± 46 min (~24-fold increase), respectively, which are consistent with the in vitro data.
Western Bloting analysis of CocE-wt and the T172R/G173Q mutant in serum following i.v.
injection in mice suggests that the intact, immunoreactive species is present for at least 2 hours (Figure 4 (B)) with no detectable proteolysis. Careful analysis of the data in Figure 4 (B) suggests that CocE-wt appears to disappear faster than the T172R/G173Q mutant (after 1 hour) but at a slower rate than suggested by the protection from lethality data (~11 min). In contrast, serum levels of the T172R/G173Q mutant appear to be unchanged two hours post-injection. These data support the notion that the improved thermostability of the T172R/G173Q mutant may account for its prolonged in vivo protective effect on the cocaine-induced lethality. The identification of thermostable mutants of CocE that display significantly longer circulation time in the body provide promising therapeutic potential for the treatment of cocaine overdose. The T172R/G173Q mutant displays an extended half-life beyond the plasma half-life of cocaine in humans (~45 to 90 min) (Landry et al., 1993) . More extensive in vivo studies on these thermostable mutants of CocE will be described elsewhere.
Discussion
Biotechnology-based therapeutics has recently garnered considerable attention in the pharmaceutical industry. The relatively lower-toxic and metabolic potential of protein-based therapeutics are their main attraction. One of the most challenging problems complicating the use This article has not been copyedited and formatted. The final version may differ from this version.
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13 of proteins as drugs is the issue of thermostability. The success in generating more thermostable forms of CocE described here suggests that our structure-and-mechanism-based design approach is a promising and efficient general computational approach for protein redesign. In particular, to design thermostable mutants of a protein, one can first perform the MD simulation on the protein at an appropriately chosen high temperature to understand the protein inactivation pathway.
Based on the detailed understanding of the protein structure and inactivation mechanism, one can carry out a virtual screening of various possible mutants through the interaction energy calculations in order to predict the most likely thermostable mutants for wet experimental tests in vitro and in vivo. This computational approach will likely represent a valuable strategy for thermostabilization of other proteins and have dramatic implications on their therapeutic potential. 
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